ArticleBlood advances2022

Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen.

A Birgitta Versluijs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.